Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/12/2025 ,inter alia, to consider and approve various matters ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed BSE that a meeting of its Rights Issue Committee will be held on December 5, 2025. The committee will decide key terms of the proposed Rights Issue, including the issue price, payment mechanism, entitlement ratio, record date, and timing. This follows the Board's earlier approval on December 1, 2025 for a Rights Issue of fully paid-up equity shares (face value Rs. 1 each) aggregating up to Rs. 49 Crores, to be offered to eligible shareholders. The trading window for designated persons has been closed from December 1, 2025 until 48 hours after the committee meeting concludes.
Existing shareholders may need to decide whether to subscribe to their entitled portion of the Rs. 49 Crore Rights Issue, which could lead to dilution if not fully subscribed. The stock may see short-term volatility around the record date announcement and pricing decision.